Table 2.
Participant Liver Disease and Cancer Risk Perception characteristics
| Characteristic | Distribution |
|---|---|
|
| |
| Etiology of liver disease | |
| Chronic hepatitis B | 14 (8) |
| Chronic hepatitis C | 37 (21)) |
| Alcoholic liver disease | 33 (18) |
| Nonalcoholic steatohepatitis | 47 (26) |
| Cryptogenic cirrhosis | 7 (4) |
| Other (includes cardiac) | 41 (25) |
| Child-Pugh class | |
| A | 136 (76) |
| B | 29 (16) |
| C | 12 (7) |
| Missing | 2 (1) |
| MELD score | |
| 1–10 | 118 (66) |
| 11–20 | 42 (24) |
| 21–30 | 15 (8) |
| Missing | 3 (2) |
| Patient perception of lifetime cancer risk | |
| Very likely | 15 (8) |
| Likely | 48 (27) |
| Neutral | 89 (50) |
| Unlikely | 20 (11) |
| Very unlikely | 7 (4) |
| Patient perception of cancer curability with early stage | |
| Very likely | 26 (15) |
| Likely | 82 (46) |
| Neutral | 49 (27) |
| Unlikely | 13 (7) |
| Very unlikely | 9 (5) |
| Patient perception of the chance of detecting cancer at an early stage with surveillance | |
| All of the time | 21 (12) |
| Most of the time | 109 (61) |
| Some of the time | 39 (22) |
| Rarely | 10 (6) |
NOTE. Values are n (%).
MELD, Model for End-Stage Liver Disease.